Prevalence of Chronic Pain 20.5 Percent in United States
Robert J. Yong, M.D., M.B.A., from Brigham and Women's Hospital in Boston, and colleagues used data from the National Health Interview Survey (NHIS) to examine the prevalence of chronic pain and its impact among adults in the United States.
The researchers found that 50.2 million adults (20.5 percent) reported pain on most days or every day based on a chronic pain module introduced into the 2019 edition of the NHIS. Back pain and hip, knee, or foot pain were the most common pain locations. Physical therapy and massage were the most commonly utilized management strategies. Limitations in daily functioning, including social activities and activities of daily living, were reported by respondents with chronic pain. Compared with those without chronic pain, respondents with chronic pain reported significantly more workdays missed (10.3 versus 2.8).
"Given the overall scale and impact of pain on Americans, we see that a multimodal, multidisciplinary approach to treating pain is even more important than what we have been emphasizing over the past few decades," Yong said in a statement. "We need all of the tools in our armamentarium to treat patients suffering from chronic pain."
© 2021 HealthDay. All rights reserved.
Posted: April 2021
Read this next
FRIDAY, April 23, 2021 -- The rate of work-related musculoskeletal disorder (WMSD) claims from overexertion among construction workers is highest for those aged 35 to 44 years,...
TUESDAY, April 6, 2021 -- Electroacupuncture and auricular acupuncture are more effective than usual care at reducing chronic musculoskeletal pain in cancer survivors, according...
WEDNESDAY, Feb. 17, 2021 -- Mean opioid consumption is increased 24 months after an episode of critical care, according to a study published online Jan. 28 in Critical Care...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.